DoD Amyotrophic Lateral Sclerosis Therapeutic Development Award

Archived

Defense Health Agency Contracting Activity - DHACA

Description

The Therapeutic Development Award supports the preclinical assessment of therapeutics for ALS. The proposed studies are expected to be empirical in nature and product-driven, but may have a hypothesis-driven approach, provided the focus is on therapeutics. It is anticipated that the agents and/or data generated from these awards will lead to the advancement of new therapies for ALS.

Who can apply

  • Unrestricted

Contact

301-682-5507
help@cdmrp.org

Key dates & funding
  • PostedApr 21, 2011
  • ClosesAug 24, 2011
  • Program funding$4,800,000
  • Expected awards2
  • CFDA12.420

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro